Group One Trading, L.P. Allogene Therapeutics, Inc. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

A detailed history of Group One Trading, L.P. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 16,162 shares of ALLO stock, worth $33,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,162
Previous 444 3540.09%
Holding current value
$33,132
Previous $1,000 4400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.08 - $3.5 $32,693 - $55,013
15,718 Added 3540.09%
16,162 $45,000
Q2 2024

Aug 14, 2024
SELL
$2.23 - $4.38 $130,410 - $256,142
-58,480 Reduced 99.25%
444 $1,000
Q1 2024

May 10, 2024
BUY
$2.92 - $5.63 $62,385 - $120,284
21,365 Added 56.88%
58,924 $263,000
Q4 2023

Feb 14, 2024
SELL
$2.28 - $3.5 $40,128 - $61,600
-17,600 Reduced 31.91%
37,559 $120,000
Q3 2023

Nov 09, 2023
BUY
$3.17 - $5.96 $152,645 - $286,991
48,153 Added 687.31%
55,159 $174,000
Q2 2023

Aug 09, 2023
SELL
$4.53 - $6.74 $16,335 - $24,304
-3,606 Reduced 33.98%
7,006 $34,000
Q1 2023

May 12, 2023
BUY
$4.92 - $8.21 $50,794 - $84,760
10,324 Added 3584.72%
10,612 $52,000
Q4 2022

Feb 09, 2023
BUY
$5.62 - $11.11 $1,618 - $3,199
288 New
288 $1,000
Q1 2022

May 12, 2022
SELL
$7.65 - $15.29 $95,319 - $190,513
-12,460 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$13.13 - $24.52 $122,686 - $229,114
9,344 Added 299.87%
12,460 $186,000
Q3 2021

Nov 12, 2021
SELL
$21.01 - $27.64 $30,128 - $39,635
-1,434 Reduced 31.52%
3,116 $80,000
Q2 2021

Aug 10, 2021
SELL
$23.49 - $35.8 $356,883 - $543,909
-15,193 Reduced 76.95%
4,550 $119,000
Q1 2021

May 12, 2021
BUY
$25.79 - $39.02 $485,625 - $734,746
18,830 Added 2062.43%
19,743 $697,000
Q4 2020

Feb 10, 2021
BUY
$25.24 - $43.45 $23,044 - $39,669
913 New
913 $23,000
Q1 2020

May 13, 2020
SELL
$18.22 - $28.25 $109,411 - $169,641
-6,005 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$24.82 - $31.4 $131,546 - $166,420
5,300 Added 751.77%
6,005 $156,000
Q3 2019

Nov 12, 2019
SELL
$26.11 - $32.99 $913 - $1,154
-35 Reduced 4.73%
705 $19,000
Q2 2019

Aug 09, 2019
BUY
$25.56 - $31.09 $12,780 - $15,545
500 Added 208.33%
740 $20,000
Q1 2019

May 13, 2019
BUY
$24.82 - $32.54 $5,956 - $7,809
240 New
240 $7,000

Others Institutions Holding ALLO

# of Institutions
162
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $295M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email